Nigeria has a long history of traditional and herbal medicine use, with a significant proportion of the population relying on these therapies for primary healthcare. Recognizing this reality, the National Agency for Food and Drug Administration and Control has taken a major step toward integrating traditional medicine into evidence-based healthcare by promoting clinical trials for herbal products.
Historically, many herbal products in Nigeria have been approved through a “listing” process, which primarily verifies safety based on available data but does not require rigorous clinical efficacy studies. While this approach allows for faster market access, it limits the ability to scientifically validate claims of effectiveness. NAFDAC is now shifting focus toward requiring structured clinical trials to establish safety, efficacy, and standardized dosing.
A key component of this initiative is collaboration with institutions such as the Nigeria Natural Medicine Development Agency (NNMDA). These partnerships aim to bridge the gap between traditional knowledge and modern scientific research. By supporting clinical trials for herbal medicines, NAFDAC is encouraging researchers and manufacturers to adopt globally accepted research standards.
This shift has several implications. First, it enhances patient safety, ensuring that widely used products are supported by credible scientific evidence. Second, it improves global acceptance of Nigerian herbal products, potentially opening doors to international markets. Third, it creates new opportunities for local researchers to engage in innovative studies that reflect indigenous health practices.
However, transitioning to this model requires overcoming challenges such as limited funding, lack of research infrastructure, and the need for specialized expertise in herbal pharmacology. Addressing these gaps will be critical to the success of this initiative.
Ultimately, NAFDAC’s push for clinical trials in herbal medicine represents a transformative step toward integrating traditional healthcare into the formal research ecosystem. It signals a future where local innovations are validated, standardized, and globally recognized.
